Sangamo Therapeutics, Inc.
SGMO
$0.4906
$0.00751.55%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | 37.67% | 61.20% | 110.25% | 68.45% | -332.29% |
| Total Depreciation and Amortization | -23.83% | -29.05% | -71.33% | -58.38% | -54.74% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -51.87% | -56.87% | -93.42% | -91.89% | -91.79% |
| Change in Net Operating Assets | 98.97% | 1,858.75% | -67.30% | 176.19% | 95.27% |
| Cash from Operations | 46.27% | 93.37% | 124.86% | 55.72% | 26.60% |
| Capital Expenditure | -- | 94.31% | 95.81% | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -100.00% | -100.00% | -100.00% | -21.96% |
| Cash from Investing | -- | -96.49% | -99.38% | -99.70% | 0.31% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -54.00% | 3,238.43% | -100.00% | -- | 147.22% |
| Repurchase of Common Stock | -453.98% | -348.98% | -100.99% | -174.74% | 63.75% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -63.23% | 4,086.23% | -103.00% | -108.18% | 176.46% |
| Foreign Exchange rate Adjustments | 290.60% | -266.08% | 304.73% | -182.11% | -282.56% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -293.97% | 124.02% | 225.19% | -141.41% | 138.86% |